Wednesday, February 4, 2015

Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function

›
Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial functio...

Mitochondrial diseases Part III: Therapeutic interventions in mouse models of oxphos deficiencies

›
Mitochondrial diseases Part III: Therapeutic interventions in mouse models of oxphos deficiencies . Mitochondrion, Available online 29 Janua...

Emerging critical roles of Fe-S clusters in DNA replication and repair

›
Emerging critical roles of Fe-S clusters in DNA replication and repair . Jill O. Fuss, Chi-Lin Tsai, Justin P. Ishida, John A. Tainer, Bioc...

Cellular Iron Uptake, Trafficking and Metabolism: Key Molecules and Mechanisms and their Roles in Disease

›
Cellular Iron Uptake, Trafficking and Metabolism: Key Molecules and Mechanisms and their Roles in Disease . D.J.R. Lane, A.M. Merlot, M.L.-H...

Iron Regulatory Protein 1 Sustains Mitochondrial Iron Loading and Function in Frataxin Deficiency

›
Iron Regulatory Protein 1 Sustains Mitochondrial Iron Loading and Function in Frataxin Deficiency . Alain Martelli, Stéphane Schmucker, Laur...
Tuesday, February 3, 2015

The promise and perils of HDAC inhibitors in neurodegeneration

›
The promise and perils of HDAC inhibitors in neurodegeneration . Alessandro Didonna and Puneet Opal; Annals of Clinical and Translational ...
Saturday, January 31, 2015

International Congress on Friedreich’s Ataxia and International conference on “DNA Structure in Health & Disease”

›
International Congress on Friedreich’s Ataxia and International conference on “DNA Structure in Health & Disease” . ; 11th -13th April...
Friday, January 30, 2015

Frataxin inactivation leads to steroid deficiency in flies and human ovarian cells

›
Frataxin inactivation leads to steroid deficiency in flies and human ovarian cells . Amandine Palandri, David L'hôte, Joëlle Cohen-Tan...

Reata Enrolls First Patient in the MOXIe Study, a Phase 2/3 Study Examining RTA 408 in Friedreich's Ataxia Patients

›
Reata Enrolls First Patient in the MOXIe Study, a Phase 2/3 Study Examining RTA 408 in Friedreich's Ataxia Patients . SOURCE: Reata Phar...
Tuesday, January 27, 2015

Project: Elucidating the molecular basis of gene silencing by an ORC-HP1 interaction and their contribution to human health disorders

›
Project: Elucidating the molecular basis of gene silencing by an ORC-HP1 interaction and their contribution to human health disorders . Pri...